145 related articles for article (PubMed ID: 26867101)
1. New Luminescent Polynuclear Metal Complexes with Anticancer Properties: Toward Structure-Activity Relationships.
Wenzel M; de Almeida A; Bigaeva E; Kavanagh P; Picquet M; Le Gendre P; Bodio E; Casini A
Inorg Chem; 2016 Mar; 55(5):2544-57. PubMed ID: 26867101
[TBL] [Abstract][Full Text] [Related]
2. New heteronuclear gold(I)-platinum(II) complexes with cytotoxic properties: are two metals better than one?
Wenzel M; Bigaeva E; Richard P; Le Gendre P; Picquet M; Casini A; Bodio E
J Inorg Biochem; 2014 Dec; 141():10-16. PubMed ID: 25172993
[TBL] [Abstract][Full Text] [Related]
3. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.
Banerjee S; Chakravarty AR
Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541
[TBL] [Abstract][Full Text] [Related]
4. Multinuclear cytotoxic metallodrugs: physicochemical characterization and biological properties of novel heteronuclear gold-titanium complexes.
Wenzel M; Bertrand B; Eymin MJ; Comte V; Harvey JA; Richard P; Groessl M; Zava O; Amrouche H; Harvey PD; Le Gendre P; Picquet M; Casini A
Inorg Chem; 2011 Oct; 50(19):9472-80. PubMed ID: 21875041
[TBL] [Abstract][Full Text] [Related]
5. Bioactive luminescent transition-metal complexes for biomedical applications.
Ma DL; He HZ; Leung KH; Chan DS; Leung CH
Angew Chem Int Ed Engl; 2013 Jul; 52(30):7666-82. PubMed ID: 23765907
[TBL] [Abstract][Full Text] [Related]
6. Trackable Metallodrugs Combining Luminescent Re(I) and Bioactive Au(I) Fragments.
Luengo A; Fernández-Moreira V; Marzo I; Gimeno MC
Inorg Chem; 2017 Dec; 56(24):15159-15170. PubMed ID: 29172469
[TBL] [Abstract][Full Text] [Related]
7. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
Lee PK; Law WH; Liu HW; Lo KK
Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537
[TBL] [Abstract][Full Text] [Related]
8. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
Pelletier F; Comte V; Massard A; Wenzel M; Toulot S; Richard P; Picquet M; Le Gendre P; Zava O; Edafe F; Casini A; Dyson PJ
J Med Chem; 2010 Oct; 53(19):6923-33. PubMed ID: 20822096
[TBL] [Abstract][Full Text] [Related]
9. A new amido-phosphine of dichloroacetic acid as an active ligand for metals of pharmaceutical interest. Synthesis, characterization and tests of antiproliferative and pro-apoptotic activity.
Marvelli L; Ferretti V; Bertolasi V; Lampronti I; Gambari R; Trapella C; Turrin G; Bonotto F; Moriello A; Bergamini P
J Inorg Biochem; 2019 Oct; 199():110787. PubMed ID: 31357068
[TBL] [Abstract][Full Text] [Related]
10. Thiolato gold(I) complexes containing water-soluble phosphane ligands: a characterization of their chemical and biological properties.
Vergara E; Cerrada E; Clavel C; Casini A; Laguna M
Dalton Trans; 2011 Nov; 40(41):10927-35. PubMed ID: 21904768
[TBL] [Abstract][Full Text] [Related]
11. Gold(III) compounds-mediated inhibition of lung cancer cell proliferation.
Bostancioğlu RB; Kaya M; Koparal AT; Benkli K
Anticancer Drugs; 2016 Mar; 27(3):225-34. PubMed ID: 26825752
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity of dmoPTA-Ru(II) complexes against human solid tumor cells.
Ríos-Luci C; León LG; Mena-Cruz A; Pérez-Roth E; Lorenzo-Luis P; Romerosa A; Padrón JM
Bioorg Med Chem Lett; 2011 Aug; 21(15):4568-71. PubMed ID: 21719285
[TBL] [Abstract][Full Text] [Related]
13. 3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure-activity relationships and stability studies on Ru(II)(arene) anticancer complexes with biologically active ligands.
Kurzwernhart A; Kandioller W; Enyedy ÉA; Novak M; Jakupec MA; Keppler BK; Hartinger CG
Dalton Trans; 2013 May; 42(17):6193-202. PubMed ID: 23168616
[TBL] [Abstract][Full Text] [Related]
14. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.
Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A
Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406
[TBL] [Abstract][Full Text] [Related]
15. Metal-based anticancer chemotherapeutic agents.
Muhammad N; Guo Z
Curr Opin Chem Biol; 2014 Apr; 19():144-53. PubMed ID: 24608084
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole.
Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M
Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072
[TBL] [Abstract][Full Text] [Related]
17. Promising anticancer mono- and dinuclear ruthenium(III) dithiocarbamato complexes: systematic solution studies.
Nagy EM; Nardon C; Giovagnini L; Marchiò L; Trevisan A; Fregona D
Dalton Trans; 2011 Nov; 40(44):11885-95. PubMed ID: 21971872
[TBL] [Abstract][Full Text] [Related]
18. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
[TBL] [Abstract][Full Text] [Related]
19. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
Li CK; Sun RW; Kui SC; Zhu N; Che CM
Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.
Saha P; Descôteaux C; Brasseur K; Fortin S; Leblanc V; Parent S; Asselin E; Bérubé G
Eur J Med Chem; 2012 Feb; 48():385-90. PubMed ID: 22209414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
